Logo - springer
Slogan - springer

Springer Healthcare | Infectious Diseases and Therapy (Editorial Board)

Infectious Diseases and Therapy

Infectious Diseases and Therapy

Co-Editor-in-Chief: M.J. Rybak, Pharm.D., MPH, Ph.D.; A. Soriano

ISSN: 2193-6382 (electronic version)

Journal no. 40121

Editors-in-Chief

USA
Michael J. Rybak, Pharm.D., MPH, Ph.D., Wayne State University, USA

Europe
Alex Soriano, M.D., Ph.D., Hospital Clínic of Barcelona, Spain

Editorial Board

Joop Arends, MD, PhD, UMC Utrecht, The Netherlands

José R. Arribas, MD, La Paz University Hospital, Spain

Patrick P. Basu, MD, Columbia University College of Physicians and Surgeons, USA

Vincent Bekker, MD, PhD, LUMC, Leiden, The Netherlands

Antonella d'Arminio Monforte, MD, San Paolo University Hospital, Italy

Sean Emery, BSc, PhD, The University of Queensland, Australia

Joel E. Gallant, MD, MPH, Johns Hopkins University School of Medicine, USA

Evangelos J. Giamarellos-Bourboulis, MD, PhD, University of Athens Medical School, Greece

Ellie J. C. Goldstein, MD, R. M. Alden Research Laboratory, USA

Adam Hersh, MD, PhD, University of Utah, USA

Michael Hornsey, BSc, MSc, PhD, University of Surrey, UK

Victoria Johnston, MD, PhD, MSc, FRCP, DTM&H, London School of Hygiene and Tropical Medicine, UK

Paul Kilgore, BSc, MPH, MD Wayne State University, USA

Keith Klugman, MD, PhD, Emory University, USA

Adriano Lazzarin, MD, San Raffaele Scientific Institute and Vita-Salute University, Italy

Donald Levine, MD, Wayne State University, USA

Miguel J. Martinez Yoldi, MD, PhD, Hospital Clinic i Provincial de Barcelona, Spain

Joseph Meletiadis, PhD, Attikon University Hospital, Greece

Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, Perelman School of Medicine, University of Pennsylvania, USA

Jason Newland, MD, MEd, Kansas City School of Medicine and Children's Mercy Hospital, USA

Kenneth V. I. Rolston, MD, University of Texas, USA

Michael Saag, MD, University of Alabama at Birmingham, USA

Andrew Ustianowski, MD, PhD, FRCP, DTM&H, North Manchester General Hospital, UK

Mark Wainberg, BSc, PhD, Jewish General Hospital, Canada

Advisory Board

Jessica L. Adams, Duha Al Zubeidi, Katie Barber, Lonneke Bode, Kalifa Bojang, Jean Carlet, Jose Luis Casado, Kimberly C. Claeys, Nancy Crum-Cianflone, Jennifer Golman, Jose Luis Górriz, Karen L. Grinnen, Sarah Jorgensen, Razieh Kebriaei, George K. K. Lau, Jennifer Li, Donna MacCallum, Francesca Mancianti, Jiachuan Pan, Mukesh Pasupuleti, Sara Pett, Jason Pogue, Raghavendra Sumanth Kumar Pudupakam, Ricardo Romiti, Warren Rose, George Sakoulas, Palash Samanta, Meenal Sinha, Jordan R. Smith, Gavin Spickett, Trang Trinh, Pierre Vaudaux, Scott Weese, James Whitney, Juwon Yim, Evan J. Zasowski, Alexandre Prehn Zavascki

Recruitment

As Infectious Diseases and Therapy continues to go from strength to strength, we are constantly looking to expand our esteemed Editorial and Advisory Reviewer Boards, and include within them individuals who may want to further their editorial experience within their range of expertise. With this in mind, if you would like to represent your research community as part of our boards, please email hannah.payne@springer.com with the following information: Name, title (Mr/Mrs/Dr/Prof), profession, affiliation/institution or company, country, telephone number, area(s) of expertise, and a brief Curriculum Vitae (CV).

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

    Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published in Infectious Diseases and Therapy may be accompanied by lay-level summaries, to assist patients (and caregivers) in understanding important medical advances.

    Moving forward from traditional publishing, Infectious Diseases and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

    Infectious Diseases and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Upon acceptance of your article for publication, you will be required to pay the article processing charge of £250/ €340/ $380 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive double-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication.

    For more information about the journal, please contact hannah.payne@springer.com.

  • Submit Online
  • Instructions for Authors (pdf, 1.1 MB)
  • Author Disclosure form (pdf, 131 kB)
  • Compliance with Ethical Policies
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    Open Access Infectious Disease and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Infectious Diseases and Therapy.